Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1831-1840 of 2905 for cancer

Edit search filters
  1. A Study To Evaluate CC-98633 To Treat Subjects With Relapsed And/or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Dose Escalation And Double-blind Study Of Veliparib In Combination With Carboplatin And Etoposide In Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  3. A Study To Evaluate T-DM1 With Or Without Abemaciclib In Women And Men With HER2-positive Advanced Or Metastatic Breast Cancer

    Jacksonville, FL, Rochester, MN

  4. A Study Comparing Tarlatamab, Durvalumab, Carboplatin, And Etoposide Versus Durvalumab, Carboplatin, And Etoposide In First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

    Rochester, MN

  5. Blood-Brain Barrier Disruption (BBBD) For Liquid Biopsy In Subjects With GlioBlastoma Brain Tumors

    Rochester, MN

  6. Erlotinib Hydrochloride And Cabozantinib-s-Malate Alone Or In Combination As Second Or Third Line Therapy In Treating Patients With Stage IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. Suppression Of Ovarian Function With Either Tamoxifen Or Exemestane Compared With Tamoxifen Alone In Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Eau Claire, WI

  8. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, Placebo‑Controlled Phase-III STudy

    Rochester, MN

  9. A Study Of Rucaparib In Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (ARIEL2)

    Jacksonville, FL, Rochester, MN

  10. Phase III Open Label Study Of MEDI 4736 With/Without Tremelimumab Versus Standard Of Care (SOC) In Recurrent/Metastatic Head And Neck Cancer

    Rochester, MN

.

Mayo Clinic Footer